Ruijuan Du
- Molecular Biology
- Oncology
- Immunology
- Cancer Research top 10%
- Cell Biology top 10%
- Co-authors
- Zigang DongXiang LiKangdong LiuChuntian HuangJeak Ling DingHui LiHua ZhaoWei Wu
- Topics
- Ferroptosis and cancer prognosis (4 papers)Ubiquitin and proteasome pathways (4 papers)Cancer-related Molecular Pathways (4 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Ruijuan Du
31 papers receiving 933 citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Biology 480
- Oncology 225
- Immunology 198
- Cancer Research 177
- Cell Biology 160
Countries citing papers authored by Ruijuan Du
This map shows the geographic impact of Ruijuan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruijuan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruijuan Du more than expected).
Fields of papers citing papers by Ruijuan Du
This network shows the impact of papers produced by Ruijuan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruijuan Du. The network helps show where Ruijuan Du may publish in the future.
Co-authorship network of co-authors of Ruijuan Du
This figure shows the co-authorship network connecting the top 25 collaborators of Ruijuan Du. A scholar is included among the top collaborators of Ruijuan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruijuan Du. Ruijuan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 15 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 7 | |
| 10 | 7 | |
| 11 | 49 | |
| 12 | Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapybreakdown → | 340 |
| 13 | 42 | |
| 14 | 33 | |
| 15 | 28 | |
| 16 | 61 | |
| 17 | 22 | |
| 18 | Lipid-free apolipoprotein A-I exerts an antioxidative role against cell-free hemoglobin. | 13 |
| 19 | 27 | |
| 20 | 35 |
About Ruijuan Du
Ruijuan Du is a scholar working on Cell Biology, Microbiology and Cancer Research, having authored 31 papers that have together received 943 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (177 citations), Cell Biology (160 citations) and Immunology (198 citations). Ruijuan Du has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Zigang Dong, Xiang Li, Kangdong Liu, Chuntian Huang, Jeak Ling Ding, Hui Li, Hua Zhao, Wei Wu, Yan Fan and Bow Ho. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.